Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Weber

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|March 16, 1996
HTLV-I screening in Britain. Antenatal screening is importantJ N Weber, G P Taylor
Science (New York, N.Y.)|June 12, 1970
Heavy carbonJ N Weber, J Onió, D A Flory
Nature|October 1, 1971
New porous biomaterials by replication of echinoderm skeletal microstructuresJ N Weber, E W White, J Lebiedzik
Journal of Medical Virology|March 1, 1992
Application of screening and confirmatory assays for anti-HTLV-I/II in U.K. populationsJ H Tosswill, J V Parry, J N Weber
The British Journal of Ophthalmology|August 1, 1987
Ophthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective studyR C Humphry, J N Weber, R J Marsh
Science (New York, N.Y.)|May 26, 1972
Replamineform: a new process for preparing porous ceramic, metal, and polymer prosthetic materialsR A White, J N Weber, E W White
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
Serotype, parental country of birth, and ethnic status in unlinked anonymous neonatal HIV seroprevalence surveysA E Ades, S Parker, J Walker, et al.
AIDS Research and Human Retroviruses|March 10, 2000
Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet UnionA F Bobkov, V V Lukashov, J Goudsmit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconateM O McBride, M Linney, R N Davidson, et al.
Genitourinary Medicine|October 1, 1985
The value of haematological screening for AIDS in an at risk populationJ N Weber, D Walker, H Engelkins, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|March 16, 1996
HTLV-I screening in Britain. Antenatal screening is importantJ N Weber, G P Taylor
Science (New York, N.Y.)|June 12, 1970
Heavy carbonJ N Weber, J Onió, D A Flory
Nature|October 1, 1971
New porous biomaterials by replication of echinoderm skeletal microstructuresJ N Weber, E W White, J Lebiedzik
Journal of Medical Virology|March 1, 1992
Application of screening and confirmatory assays for anti-HTLV-I/II in U.K. populationsJ H Tosswill, J V Parry, J N Weber
The British Journal of Ophthalmology|August 1, 1987
Ophthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective studyR C Humphry, J N Weber, R J Marsh
Science (New York, N.Y.)|May 26, 1972
Replamineform: a new process for preparing porous ceramic, metal, and polymer prosthetic materialsR A White, J N Weber, E W White
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
Serotype, parental country of birth, and ethnic status in unlinked anonymous neonatal HIV seroprevalence surveysA E Ades, S Parker, J Walker, et al.
AIDS Research and Human Retroviruses|March 10, 2000
Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet UnionA F Bobkov, V V Lukashov, J Goudsmit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconateM O McBride, M Linney, R N Davidson, et al.
Genitourinary Medicine|October 1, 1985
The value of haematological screening for AIDS in an at risk populationJ N Weber, D Walker, H Engelkins, et al.
Pageof 12